Location: San Diego, CA
CIK: 0001232621 · Show all filings
Period: Q1 2017 (← Previous) (Next →)
Filing Date: May 15, 2017
Total Value: $277M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS INC | 8,654,914 | $130M | 46.9% | $13.92 | -0.5% | COM | 427746102 |
| — | LA JOLLA PHARMACEUTICAL CO | 3,440,419 | $103M | 37.1% | $16.25 | — | COM | 503459604 |
| — | IGNYTA INC | 3,972,800 | $34.17M | 12.3% | $5.43 | — | COM | 451731103 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 90,215 | $7.919M | 2.9% | $62.32 | +42.8% | COM | 09061G101 |
| — | CYCLACEL PHARMACEUTICALS INC | 559,900 | $2.06M | 0.7% | $5.17 | — | COM | 23254L405 |